GSK3B and Alzheimer disease: We extended these findings by showing that lateral ventricle injection of GSK3β inhibitor strengthened GABAergic inhibition and glutamatergic excitation in pyramidal neurons of the prefrontal cortex in 3 × Tg-AD mice (Figure 6).